NDC 65219-670 – Bomyntra

Denosumab 70 mg/mL · Injection · Subcutaneous

Human Prescription Drug

Product NDC65219-670

Product details

Brand name
Bomyntra
Generic name
Denosumab
Labeler
Fresenius Kabi USA, LLC
Dosage form
Injection
Route
Subcutaneous
Marketing category
BLA · BLA761398
Marketed since
June 30, 2025
Listing expires
December 31, 2026
Pharmacologic class
RANK Ligand Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Bomyntra →

Package NDC codes (1)

Package NDCDescriptionSince
65219-670-011 VIAL, SINGLE-DOSE in 1 CARTON (65219-670-01) / 1.7 mL in 1 VIAL, SINGLE-DOSEJun 30, 2025

Other Bomyntra products